Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health.

The article focuses on expansion of the priority review voucher program of pharmaceutical manufacturer Under the U.S. 21st Century Cures Act. Topics discussed include drug approval process of the Food and Drug Administration; efforts of the government in improving public health; and mandating innovation for treating neglected diseases.